Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.

ABSTRACT:

Background

Rotavirus vaccination was included into the Norwegian childhood immunisation programme in 2014. Before implementation, rotavirus vaccination was found to be cost-effective from a societal perspective, but not from a healthcare perspective. Since introduction, new data on the incidence and economic effects of rotavirus disease have become available. We assessed early epidemiological effects of the rotavirus vaccination programme and re-evaluated its cost-effectiveness in Norway for the years 2015-2019.

Methods

Using a dynamic transmission model, we compared the epidemiological effects of the ongoing two-dose vaccination programme with Rotarix®, and a hypothetical 3-dose programme with RotaTeq® with no vaccination. A baseline cost of € 54 per fully vaccinated child

SUBMITTER: Hansen Edwards C 

PROVIDER: S-EPMC5560584 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature